Cambridge Cognition Holdings PLC
LSE:COG

Watchlist Manager
Cambridge Cognition Holdings PLC Logo
Cambridge Cognition Holdings PLC
LSE:COG
Watchlist
Price: 28 GBX 1.82% Market Closed
Market Cap: 11.7m GBX
Have any thoughts about
Cambridge Cognition Holdings PLC?
Write Note

Cambridge Cognition Holdings PLC
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cambridge Cognition Holdings PLC
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Cambridge Cognition Holdings PLC
LSE:COG
Common Stock
ÂŁ417k
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
9%
Renalytix PLC
LSE:RENX
Common Stock
$299k
CAGR 3-Years
16%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Craneware PLC
LSE:CRW
Common Stock
$659k
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
3%
Intelligent Ultrasound Group PLC
LSE:IUG
Common Stock
ÂŁ3.3m
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
N/A
EMIS Group PLC
LSE:EMIS
Common Stock
ÂŁ633k
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Doctor Care Anywhere Group PLC
ASX:DOC
Common Stock
ÂŁ78k
CAGR 3-Years
4%
CAGR 5-Years
32%
CAGR 10-Years
N/A
No Stocks Found

Cambridge Cognition Holdings PLC
Glance View

Market Cap
11.7m GBX
Industry
Health Care

Cambridge Cognition Holdings Plc is a neuroscience digital health company, which engages in the development of digital health products to better understand, detect, and treat conditions affecting brain health. The firm develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.

COG Intrinsic Value
104.23 GBX
Undervaluation 73%
Intrinsic Value
Price

See Also

What is Cambridge Cognition Holdings PLC's Common Stock?
Common Stock
417k GBP

Based on the financial report for Jun 30, 2024, Cambridge Cognition Holdings PLC's Common Stock amounts to 417k GBP.

What is Cambridge Cognition Holdings PLC's Common Stock growth rate?
Common Stock CAGR 10Y
9%

Over the last year, the Common Stock growth was 19%. The average annual Common Stock growth rates for Cambridge Cognition Holdings PLC have been 10% over the past three years , 11% over the past five years , and 9% over the past ten years .

Back to Top